PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28797524-9	2017	CONCLUSION: The combined therapy of SGLT2 inhibitor along with metformin is more effective in HbA1c reduction and weight reduction as compared to monotherapy using metformin alone.	Metformin	63-72	hemoglobin subunit alpha 1	Homo sapiens	94-98	
28797524-9	2017	CONCLUSION: The combined therapy of SGLT2 inhibitor along with metformin is more effective in HbA1c reduction and weight reduction as compared to monotherapy using metformin alone.	Metformin	164-173	hemoglobin subunit alpha 1	Homo sapiens	94-98